HTA277 Readying for the Second Wave: What, When, and How Must Orphan Medicine Manufacturers Prepare for EU HTAR?
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.2060
https://www.valueinhealthjournal.com/article/S1098-3015(25)04617-0/fulltext
Title :
HTA277 Readying for the Second Wave: What, When, and How Must Orphan Medicine Manufacturers Prepare for EU HTAR?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)04617-0&doi=10.1016/j.jval.2025.09.2060
First page :
Section Title :
Open access? :
No
Section Order :
11602